The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

bioone.jp

Stage

Other Investors | Alive

About BioOne

BioOne offers the Intercept Blood System, a system to inactivate pathogens and lymphocytes in blood products. The technology was developed by Cerus Corporation

BioOne Headquarter Location

Daiichikangin-Inagaki Building 8F, 2-1, Shimomiyabi-cho

162-0822,

Japan

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest BioOne News

Greiner BioOne Launches New MiniCollect K2EDTA Capillary Tube into the Healthcare Market

May 10, 2019

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190510005287/en/ When the MiniCollect® K2EDTA Capillary Collection Tube is threaded into a 13x75mm carrier tube, the combination takes on the functionality of a standard blood collection tube. In addition, the MiniCollect® Complete offers the advantage of having the MiniCollect® permanently affixed to the carrier tube, which can be labeled as the primary tube. Greiner Bio-One North America, Inc. is a privately held plastic manufacturing company located in Monroe, NC whose three divisions manufacture a variety of products for the medical and research fields. The manufactured products include plasticware for the cultivation and analysis of cell and tissue cultures, microplates for high-throughput screening related to drug screening, products for blood and specimen collection, tests for the detection of bacteria and viruses, as well as, custom-made products. As an international manufacturer with global reach, Greiner Bio-One provides the manufacturing, distribution logistics and product application support to the world’s largest hospitals, pharmaceutical and biotechnology corporations. For more information about Greiner Bio-One North America, Inc. please visit http://www.gbo.com . View source version on businesswire.com: https://www.businesswire.com/news/home/20190510005287/en/ Mackenzie Farone-Waite +1(704) 261 7800

  • What is BioOne's latest funding round?

    BioOne's latest funding round is Other Investors.

  • Who are the investors of BioOne?

    Investors of BioOne include Mitsubishi UFJ Capital.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.